Ondansetron hydrochloride tablets, the generic equivalent of GlaxoSmithKline’s Zofran tablets, will be available in 4 mg and 8 mg strengths. Ondansetron hydrochloride tablets are indicated for prevention of nausea and vomiting due to cancer chemotherapy, radiation surgery and therapy. Annual sales of Ondansetron hydrochloride tablets in the U.S. Were approximately US$746 million for the a year ending March 2007 according to IMS Health data.. Actavis launches Ondansetron tablets in the U.S.S. Actavis will market the merchandise under an agreement with Natco Pharma Limited. Distribution of the product will commence immediately.Finally, Agios researcher Valeria Fantin, Ph.D., gave an oral demonstration ‘Cancer-connected mutations in IDH1 and IDH2 produce 2HG,’ on Monday, April 19, discussing the results of this research, which were the basis of a Character publication in November 2009.
Alameda Alliance for Wellness utilizes MedeAnalytics’ analytic answers to improve member outcomes, services MedeAnalytics, a leading provider of healthcare performance management solutions, today that Alameda Alliance for Wellness announced, located in Alameda, Calif., offers selected MedeAnalytics’ Provider Network Administration Analytics and Medical Management Analytics solutions. The Alliance will utilize these analytic answers to improve member outcomes and providers. MedeAnalytics will help us recognize emerging trends and problems impacting our membership and network suppliers.